JPH0453847B2 - - Google Patents

Info

Publication number
JPH0453847B2
JPH0453847B2 JP59250313A JP25031384A JPH0453847B2 JP H0453847 B2 JPH0453847 B2 JP H0453847B2 JP 59250313 A JP59250313 A JP 59250313A JP 25031384 A JP25031384 A JP 25031384A JP H0453847 B2 JPH0453847 B2 JP H0453847B2
Authority
JP
Japan
Prior art keywords
substance
weight
therapy
dialysis
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59250313A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61129130A (ja
Inventor
Juji Maeda
Hideyuki Yamato
Takami Fujii
Yasuhiko Kobayashi
Kenichi Saito
Tadaaki Kato
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP59250313A priority Critical patent/JPS61129130A/ja
Priority to US06/800,114 priority patent/US4628050A/en
Publication of JPS61129130A publication Critical patent/JPS61129130A/ja
Publication of JPH0453847B2 publication Critical patent/JPH0453847B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59250313A 1984-11-27 1984-11-27 抗尿毒症剤 Granted JPS61129130A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP59250313A JPS61129130A (ja) 1984-11-27 1984-11-27 抗尿毒症剤
US06/800,114 US4628050A (en) 1984-11-27 1985-11-20 Antinephritic pharmaceutical composition containing 24, 25-dihydroxycholecalciferol as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59250313A JPS61129130A (ja) 1984-11-27 1984-11-27 抗尿毒症剤

Publications (2)

Publication Number Publication Date
JPS61129130A JPS61129130A (ja) 1986-06-17
JPH0453847B2 true JPH0453847B2 (en]) 1992-08-27

Family

ID=17206048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59250313A Granted JPS61129130A (ja) 1984-11-27 1984-11-27 抗尿毒症剤

Country Status (2)

Country Link
US (1) US4628050A (en])
JP (1) JPS61129130A (en])

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
DE3812524A1 (de) * 1988-04-15 1989-10-26 Fresenius Ag Dialysier- und spuelloesung fuer die intraperitoneale verabreichung mit antimikrobieller ausruestung
KR950000153A (ko) * 1993-06-21 1995-01-03 아라끼 타다시 신성골이영양증(Renal Osteodystrophy)의 골질량감소 억제제
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135812A (ja) * 1982-02-08 1983-08-12 Kureha Chem Ind Co Ltd マグネシウム代謝調節剤
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases

Also Published As

Publication number Publication date
US4628050A (en) 1986-12-09
JPS61129130A (ja) 1986-06-17

Similar Documents

Publication Publication Date Title
US4590184A (en) Antiosteoporotic pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient
JP2001513487A (ja) 糖尿病治療用組成物及び治療方法
WO1995017889A1 (fr) Composition therapeutique utile pour traiter l'hyperparathyroidie d'un patient en dialyse artificielle
JP2014148520A (ja) 閉経後の女性および下等動物における脂溶性ビタミンの腸吸収を増進する際の方法
JPH05194209A (ja) 血管内皮細胞機能改善剤
JPH0453847B2 (en])
Park et al. Fatal pulmonary involvement in dermatomyositis
Rothwell et al. Does fish oil benefit stone formers?
JPH0699310B2 (ja) アセトアルデヒド解毒剤
Warner et al. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
US20250099415A1 (en) Methods for Inhibiting the Progression of Oxidative Retinal Disease
JPH0372206B2 (en])
JPH0372207B2 (en])
US4866047A (en) Method for inhibiting the formation of urinary calculus utilizing 24,25-(OH)2 -D3
JPS6259091B2 (en])
JP2876547B2 (ja) 抗クル病剤
JPS6221330B2 (en])
US4501737A (en) Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat myodystrophia
JPH0371411B2 (en])
JPS61130227A (ja) 腫瘍における疼痛軽減剤
EP0313703B1 (en) Use of 24,25-dihydroxycholecalciferole in the treatment of urinary calculus
JPH08208464A (ja) 高脂血症の治療及び予防薬
JPH03291220A (ja) アスコクロリン誘導体を有効成分とするＣａ代謝異常改善剤
WO2025114474A1 (en) Compositions for use in preventing or treating renal failure and associated disorders
JPS63166829A (ja) 骨強度増強剤